VRCA Verrica Pharmaceuticals Inc.
Nasdaq · SEC CIK 1660334 · EDGAR
- Bought, last 12 months
- $18.17M 10 purchases by 5 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 102 since 2021-07-20, latest 2026-08-18 17:00
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Manning Paul B | Dir, 10% | $17.49M | — |
| Rieger Jayson | CEO, Pres, Dir | $525.6K | — |
| Zawitz David | COO | $72.3K | — |
| Rosenberg Noah L. | CMO | $40.6K | — |
| Kirby John J. | Interim CFO | $39.6K | — |
Transactions 71
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 17:00 | 2026-08-17 | VRCA | Zawitz David | COO | P - Purchase | $4.98 | +6,000 | 27.0K | +29% | +$29.9K | |
| M | 2026-08-18 17:00 | 2026-08-17+ | VRCA | Rosenberg Noah L. | CMO | P - Purchase | $4.91 | +6,230 | 8,587 | +264% | +$30.6K |
| M | 2026-08-18 17:00 | 2026-08-14+ | VRCA | Rieger Jayson | CEO, Pres, Dir | P - Purchase | $5.03 | +25.0K | 207.6K | +14% | +$125.7K |
| 2026-08-18 17:00 | 2026-08-18 | VRCA | Kirby John J. | Interim CFO | P - Purchase | $4.93 | +5,000 | 24.0K | +26% | +$24.6K | |
| 2025-12-30 | 2025-12-23 | VRCA | Kirby John J. | Interim CFO | A - Grant | $0.00 | +10.0K | 19.0K | +112% | $0 | |
| D | 2025-11-25 | 2025-11-25 | VRCA | Manning Paul B | Dir, 10% | P - Purchase | $4.24 | +1.38M | 3.96M | +53% | +$5.83M |
| DI | 2025-11-25 | 2025-11-25 | VRCA | Manning Paul B | Dir, 10% | P - Purchase | $4.24 | +2.75M | 3.35M | +460% | +$11.66M |
| D | 2025-11-25 | 2025-11-25 | VRCA | Zawitz David | COO | P - Purchase | $4.24 | +10.0K | 21.0K | +91% | +$42.4K |
| D | 2025-11-25 | 2025-11-25 | VRCA | Rieger Jayson | CEO, Pres, Dir | P - Purchase | $4.24 | +94.3K | 182.6K | +107% | +$399.9K |
| D | 2025-11-25 | 2025-11-25 | VRCA | Kirby John J. | Interim CFO | P - Purchase | $4.24 | +3,536 | 8,962 | +65% | +$15.0K |
| D | 2025-11-25 | 2025-11-25 | VRCA | Rosenberg Noah L. | CMO | P - Purchase | $4.24 | +2,357 | 2,357 | New | +$9,994 |
| D | 2025-03-18 | 2025-03-17 | VRCA | Hayes Christopher G. | CLO | S - Sale | $0.65 | -4,315 | 176.5K | -2% | -$2,805 |
| A | 2025-02-06 | 2023-08-24 | VRCA | Goldenberg Gary | Chief Medical Off | A - Grant | $0.00 | +50.0K | 120.1K | +71% | $0 |
| A | 2025-02-06 | 2023-08-24 | VRCA | Kohler Terry | CFO | A - Grant | $0.00 | +125.0K | 125.0K | New | $0 |
| A | 2025-02-06 | 2023-08-24 | VRCA | Hayes Christopher G. | CLO | A - Grant | $0.00 | +150.0K | 231.9K | +183% | $0 |
| A | 2025-02-06 | 2023-08-24 | VRCA | Bonaccorso Joe | Chief COMMERCIAL Off | A - Grant | $0.00 | +125.0K | 187.7K | +199% | $0 |
| A | 2025-02-06 | 2023-08-24 | VRCA | White Ted | Pres AND CEO, Dir | A - Grant | $0.00 | +150.0K | 278.8K | +116% | $0 |
| D | 2024-11-26 | 2024-11-26 | VRCA | Stalfort John A III | Dir | G - Gift | $0.00 | +50.0K | 1.87M | +3% | $0 |
| D | 2024-11-26 | 2024-11-22 | VRCA | Stalfort John A III | Dir | P - Purchase | — | +1.12M | 1.82M | +160% | — |
| DI | 2024-11-26 | 2024-11-22 | VRCA | Manning Paul B | Dir, 10% | P - Purchase | — | +4.49M | 5.98M | +303% | — |
| D | 2024-11-26 | 2024-11-22 | VRCA | Manning Paul B | Dir, 10% | P - Purchase | — | +18.43M | 26.28M | +235% | — |
| D | 2024-11-26 | 2024-11-26 | VRCA | Manning Paul B | Dir, 10% | G - Gift | $0.00 | -450.0K | 25.83M | -2% | $0 |
| D | 2024-11-26 | 2024-11-26 | VRCA | Rieger Jayson | CEO, Pres, Dir | G - Gift | $0.00 | +50.0K | 882.8K | +6% | $0 |
| D | 2024-11-26 | 2024-11-22 | VRCA | Rieger Jayson | CEO, Pres, Dir | P - Purchase | — | +280.9K | 832.8K | +51% | — |
| 2024-11-06 | 2024-11-06 | VRCA | Kirby John J. | Interim CFO | A - Grant | $0.00 | +54.3K | 54.3K | New | $0 | |
| MI | 2024-09-23 | 2024-09-19 | VRCA | Manning Paul B | Dir, 10% | G - Gift | $0.00 | +0.00 | 0 | New | $0 |
| M | 2024-08-28 | 2024-08-26+ | VRCA | Kohler Terry | CFO | S - Sale | $2.61 | -29.7K | 44.7K | -40% | -$77.5K |
| M | 2024-08-28 | 2024-08-26+ | VRCA | Hayes Christopher G. | CLO | S - Sale | $2.61 | -35.7K | 105.8K | -25% | -$93.1K |
| M | 2024-08-28 | 2024-08-26+ | VRCA | White Ted | Pres AND CEO, Dir | S - Sale | $2.61 | -34.0K | 216.0K | -14% | -$88.6K |
| M | 2024-08-28 | 2024-08-26+ | VRCA | Goldenberg Gary | Chief Medical Off | S - Sale | $2.61 | -13.5K | 97.9K | -12% | -$35.2K |
| M | 2024-08-28 | 2024-08-26+ | VRCA | Bonaccorso Joe | Chief COMMERCIAL Off | S - Sale | $2.61 | -33.7K | 73.1K | -32% | -$87.8K |
| M | 2024-07-23 | 2024-07-22+ | VRCA | Goldenberg Gary | Chief Medical Off | S - Sale | $7.06 | -18.5K | 107.8K | -15% | -$130.7K |
| M | 2024-07-23 | 2024-07-22+ | VRCA | White Ted | Pres AND CEO, Dir | S - Sale | $7.06 | -32.6K | 250.1K | -12% | -$230.3K |
| M | 2024-07-23 | 2024-07-22+ | VRCA | Hayes Christopher G. | CLO | S - Sale | $7.06 | -21.7K | 141.6K | -13% | -$153.5K |
| M | 2024-07-23 | 2024-07-22+ | VRCA | Bonaccorso Joe | Chief COMMERCIAL Off | S - Sale | $7.06 | -25.6K | 106.8K | -19% | -$180.6K |
| D | 2024-03-19 | 2024-03-15 | VRCA | Hayes Christopher G. | CLO | A - Grant | $0.00 | +40.0K | 163.2K | +32% | $0 |
| D | 2024-03-19 | 2024-03-15 | VRCA | Kohler Terry | CFO | A - Grant | $0.00 | +40.0K | 74.4K | +116% | $0 |
| D | 2024-03-19 | 2024-03-15 | VRCA | Goldenberg Gary | Chief MEDICAL Off | A - Grant | $0.00 | +40.0K | 126.3K | +46% | $0 |
| D | 2024-03-19 | 2024-03-15 | VRCA | White Ted | Pres AND CEO, Dir | A - Grant | $0.00 | +112.5K | 282.6K | +66% | $0 |
| D | 2024-03-19 | 2024-03-15 | VRCA | Bonaccorso Joe | Chief COMMERCIAL Off | A - Grant | $0.00 | +40.0K | 132.4K | +43% | $0 |
| MI | 2023-12-29 | 2023-12-27+ | VRCA | EDELMAN JOSEPH | 10% | P - Purchase | $7.17 | +321.6K | 6.98M | +5% | +$2.31M |
| MI | 2023-12-26 | 2023-12-21+ | VRCA | PERCEPTIVE ADVISORS LLC | 10% | P - Purchase | $6.45 | +504.7K | 6.72M | +8% | +$3.26M |
| MI | 2023-12-19 | 2023-12-15+ | VRCA | PERCEPTIVE ADVISORS LLC | 10% | P - Purchase | $5.63 | +1.23M | 6.00M | +26% | +$6.94M |
| M | 2023-11-16 | 2023-11-14+ | VRCA | Kohler Terry | CFO | S - Sale | $2.94 | -28.1K | 44.0K | -39% | -$82.7K |
| M | 2023-11-16 | 2023-11-14+ | VRCA | Goldenberg Gary | Chief Medical Off | S - Sale | $2.94 | -8,853 | 86.3K | -9% | -$26.1K |
| M | 2023-11-16 | 2023-11-14+ | VRCA | Hayes Christopher G. | CLO | S - Sale | $2.94 | -33.7K | 123.2K | -21% | -$99.2K |
| M | 2023-11-16 | 2023-11-14+ | VRCA | Bonaccorso Joe | Chief Commercial Off | S - Sale | $2.94 | -32.8K | 103.7K | -24% | -$96.7K |
| M | 2023-11-16 | 2023-11-14+ | VRCA | White Ted | Pres, CEO, Dir | S - Sale | $2.94 | -33.7K | 181.6K | -16% | -$99.2K |
| 2023-08-28 | 2023-08-24 | VRCA | Hayes Christopher G. | CLO | A - Grant | $0.00 | +75.0K | 156.9K | +92% | $0 | |
| 2023-08-28 | 2023-08-24 | VRCA | Kohler Terry | CFO | A - Grant | $0.00 | +62.5K | 62.5K | New | $0 | |
| 2023-08-28 | 2023-08-24 | VRCA | Bonaccorso Joe | Chief Commercial Off | A - Grant | $0.00 | +62.5K | 125.2K | +100% | $0 | |
| 2023-08-28 | 2023-08-24 | VRCA | Goldenberg Gary | Chief Medical Off | A - Grant | $0.00 | +25.0K | 95.1K | +36% | $0 | |
| 2023-08-28 | 2023-08-24 | VRCA | White Ted | Pres, CEO, Dir | A - Grant | $0.00 | +75.0K | 203.8K | +58% | $0 | |
| 2023-07-25 | 2023-07-21 | VRCA | White Ted | Pres, CEO, Dir | A - Grant | $0.00 | +150.0K | 179.5K | +509% | $0 | |
| 2023-07-25 | 2023-07-24 | VRCA | White Ted | Pres, CEO, Dir | S - Sale | $4.83 | -50.7K | 128.8K | -28% | -$244.8K | |
| 2023-07-25 | 2023-07-21 | VRCA | Hayes Christopher G. | CLO | A - Grant | $0.00 | +100.0K | 115.7K | +636% | $0 | |
| 2023-07-25 | 2023-07-24 | VRCA | Hayes Christopher G. | CLO | S - Sale | $4.83 | -33.8K | 81.9K | -29% | -$163.2K | |
| 2023-07-25 | 2023-07-24 | VRCA | Bonaccorso Joe | Chief Commercial Off | S - Sale | $4.83 | -38.3K | 62.7K | -38% | -$184.8K | |
| 2023-07-25 | 2023-07-21 | VRCA | Bonaccorso Joe | Chief Commercial Off | A - Grant | $0.00 | +100.0K | 101.0K | +10,000% | $0 | |
| 2023-07-25 | 2023-07-21 | VRCA | Goldenberg Gary | Chief Medical Off | A - Grant | $0.00 | +75.0K | 98.8K | +315% | $0 | |
| 2023-07-25 | 2023-07-24 | VRCA | Goldenberg Gary | Chief Medical Off | S - Sale | $4.83 | -28.7K | 70.1K | -29% | -$138.6K | |
| 2023-07-24 | 2023-07-24 | VRCA | Manning Paul B | Dir, 10% | P - Purchase | $5.02 | +200.0K | 7.85M | +3% | +$1.00M | |
| A | 2023-02-21 | 2022-07-05 | VRCA | White Ted | Pres, CEO, Dir | P - Purchase | $2.10 | +7,500 | 29.5K | +34% | +$15.8K |
| 2022-07-11 | 2022-07-11 | VRCA | Hayes Christopher G. | CLO | P - Purchase | $3.40 | +7,500 | 15.7K | +91% | +$25.5K | |
| 2022-07-05 | 2022-07-05 | VRCA | Manning Paul B | Dir, 10% | P - Purchase | $2.10 | +4.76M | 13.65M | +54% | +$10.00M | |
| 2022-07-05 | 2022-07-05 | VRCA | Goldenberg Gary | Chief Medical Off | P - Purchase | $2.10 | +23.8K | 23.8K | New | +$50.0K | |
| 2022-07-05 | 2022-07-05 | VRCA | Hayes Christopher G. | CLO | P - Purchase | $2.10 | +5,714 | 8,214 | +229% | +$12.0K | |
| 2022-07-05 | 2022-07-05 | VRCA | Stalfort John A III | Dir | P - Purchase | $2.10 | +238.1K | 700.2K | +52% | +$500.0K | |
| 2022-07-05 | 2022-07-05 | VRCA | White Ted | Pres, CEO, Dir | P - Purchase | $2.10 | +23.8K | 29.5K | +421% | +$50.0K | |
| I | 2022-07-05 | 2022-07-05 | VRCA | PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 10% | P - Purchase | $2.10 | +1.43M | 5.04M | +40% | +$3.00M |
| M | 2021-12-06 | 2021-12-02+ | VRCA | Manning Paul B | Dir, 10% | P - Purchase | $9.36 | +50.0K | 8.15M | +0.6% | +$467.9K |
Purchase Sale Sale after option exercise All abbreviations